Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | NA | High |
Rating | 2.0 | 4.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.2 | 1.72 |
NAV | ₹30.34 | ₹77.43 |
Fund Started | 24 May 2010 | 16 Feb 2004 |
Fund Size | ₹270.65 Cr | ₹3264.25 Cr |
Exit Load | Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 1 months. | Exit load for units in excess of 30% of the investment,1% will be charged for redemption within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 5.77% | 7.97% |
3 Year | 7.31% | 10.26% |
5 Year | 7.67% | 9.92% |
1 Year
3 Year
5 Year
Equity | 18.86% | 22.04% |
Cash | 1.94% | 8.38% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
HDFC Bank Ltd. | 2.18% |
Reliance Industries Ltd. | 1.63% |
State Bank of India | 1.34% |
Infosys Ltd. | 1.34% |
ICICI Bank Ltd. | 1.32% |
Larsen & Toubro Ltd. | 1.02% |
Cipla Ltd. | 0.91% |
Bharti Airtel Ltd. | 0.79% |
NTPC Ltd. | 0.77% |
Cholamandalam Investment and Finance Company Ltd. | 0.65% |
Name | Assets |
|---|---|
ICICI Bank Ltd. | 1.54% |
SBI Life Insurance Company Ltd. | 1.31% |
Maruti Suzuki India Ltd. | 1.02% |
HDFC Life Insurance Co Ltd. | 1.00% |
HDFC Bank Ltd. | 0.99% |
Infosys Ltd. | 0.97% |
NTPC Ltd. | 0.94% |
Hindustan Unilever Ltd. | 0.93% |
Sun Pharmaceutical Industries Ltd. | 0.87% |
Axis Bank Ltd. | 0.87% |
Name | Devang Shah | Ritesh Lunawat |
Start Date | 28 Oct 2025 | 28 Dec 2020 |
Name
Start Date
Description | The fund seeks to generate regular income through investments in debt and money market securities. | The scheme seeks to generate long-term capital appreciation by investments in money market and debt instruments. |
Launch Date | 24 May 2010 | 16 Feb 2004 |
Description
Launch Date